Literature DB >> 6066689

Prediction of improvement in schizophrenia under four phenothiazines.

S C Goldberg, N Mattsson, J O Cole, G L Klerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6066689     DOI： 10.1001/archpsyc.1967.01730190109015

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  6 in total

Review 1.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

2.  Efficacy of loxapine in the treatment of paranoid schizophrenia.

Authors:  M P Bishop; G M Simpson; C W Dunnett; H Kiltie
Journal:  Psychopharmacology (Berl)       Date:  1977-01-31       Impact factor: 4.530

Review 3.  Fluphenazine (oral) versus placebo for schizophrenia.

Authors:  Hosam E Matar; Muhammad Qutayba Almerie; Stephanie Sampson
Journal:  Cochrane Database Syst Rev       Date:  2013-07-17

4.  Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Authors:  S R Hirsch; R Gaind; P D Rohde; B C Stevens; J K Wing
Journal:  Br Med J       Date:  1973-03-17

Review 5.  Thioridazine for schizophrenia.

Authors:  M Fenton; J Rathbone; J Reilly; A Sultana
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 6.  Fluphenazine (oral) versus placebo for schizophrenia.

Authors:  Hosam E Matar; Muhammad Qutayba Almerie; Stephanie J Sampson
Journal:  Cochrane Database Syst Rev       Date:  2018-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.